Introduction ALAN KNOX, ANDREW SZCZEKLIK, and GIAMPIERO PATRIARCA Thorax 2000; 55 (Suppl 2): S1-S2. doi:10.1136/thorax.55.suppl_2.S1 [Extract] [Full text] [PDF] [Request Permissions]
	Aspirin and other anti-inflammatory drugs Sir John Vane Thorax 2000; 55 (Suppl 2): S3-S9. doi:10.1136/thorax.55.suppl_2.S3 [Extract] [Full text] [PDF] [Request Permissions]
	Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking Charles N Serhan and Clary B Clish Thorax 2000; 55 (Suppl 2): S10-S12. doi:10.1136/thorax.55.suppl_2.S10 [Extract] [Full text] [PDF] [Request Permissions]
	A new class of lipid mediators: cytochrome P450 arachidonate metabolites Mairead A Carroll and John C McGiff Thorax 2000; 55 (Suppl 2): S13-S16. doi:10.1136/thorax.55.suppl_2.S13 [Extract] [Full text] [PDF] [Request Permissions]
	Unusual effects of aspirin on ticlopidine induced thrombolysis R J Gryglewski, W Uracz, and J Swies Thorax 2000; 55 (Suppl 2): S17-S19. doi:10.1136/thorax.55.suppl_2.S17 [Extract] [Full text] [PDF] [Request Permissions]
	Epidemiology of chronic rhinosinusitis P Van Cauwenberge and J B Watelet Thorax 2000; 55 (Suppl 2): S20-S21. doi:10.1136/thorax.55.suppl_2.S20 [Extract] [Full text] [PDF] [Request Permissions]
	Perennial allergic rhinitis and keratoconjunctivitis J P Rihoux Thorax 2000; 55 (Suppl 2): S22-S23. doi:10.1136/thorax.55.suppl_2.S22 [Extract] [Full text] [PDF] [Request Permissions]
	Haemopoietic mechanisms in nasal polyposis and asthma Judah A Denburg Thorax 2000; 55 (Suppl 2): S24-S25. doi:10.1136/thorax.55.suppl_2.S24 [Extract] [Full text] [PDF] [Request Permissions]
	United airways disease: therapeutic aspects Giovanni Passalacqua, Giorgio Ciprandi, and Giorgio Walter Canonica Thorax 2000; 55 (Suppl 2): S26-S27. doi:10.1136/thorax.55.suppl_2.S26 [Extract] [Full text] [PDF] [Request Permissions]
	Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast A P Sampson, S Siddiqui, D Buchanan, P H Howarth, S T Holgate, J W Holloway, and I Sayers Thorax 2000; 55 (Suppl 2): S28-S31. doi:10.1136/thorax.55.suppl_2.S28 [Extract] [Full text] [PDF] [Request Permissions]
	Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways Alan R Leff Thorax 2000; 55 (Suppl 2): S32-S37. doi:10.1136/thorax.55.suppl_2.S32 [Extract] [Full text] [PDF] [Request Permissions]
	Lipoxins and other arachidonate derived mediators in bronchial asthma C Chavis, I Vachier, P Godard, J Bousquet, and P Chanez Thorax 2000; 55 (Suppl 2): S38-S41. doi:10.1136/thorax.55.suppl_2.S38 [Extract] [Full text] [PDF] [Request Permissions]
	Clinical features and diagnosis of aspirin induced asthma Andrzej Szczeklik and Ewa Nizankowska Thorax 2000; 55 (Suppl 2): S42-S44. doi:10.1136/thorax.55.suppl_2.S42 [Extract] [Full text] [PDF] [Request Permissions]
	Genetics of aspirin induced asthma Marek Sanak and Andrzej Szczeklik Thorax 2000; 55 (Suppl 2): S45-S47. doi:10.1136/thorax.55.suppl_2.S45 [Extract] [Full text] [PDF] [Request Permissions]
	Inhaled transmembrane ion transport modulators and non-steroidal anti-inflammatory drugs in asthma S Bianco, M Robuschi, A Vaghi, A Fumagalli, and P Sestini Thorax 2000; 55 (Suppl 2): S48-S50. doi:10.1136/thorax.55.suppl_2.S48 [Extract] [Full text] [PDF] [Request Permissions]
	Oxidant stress in asthma Ryszard Dworski Thorax 2000; 55 (Suppl 2): S51-S53. doi:10.1136/thorax.55.suppl_2.S51 [Extract] [Full text] [PDF] [Request Permissions]
	The importance of COX-2 inhibition for aspirin induced asthma Alan Bennett Thorax 2000; 55 (Suppl 2): S54-S56. doi:10.1136/thorax.55.suppl_2.S54 [Extract] [Full text] [PDF] [Request Permissions]
	Chronic bronchial asthma from challenge to treatment: epidemiology and social impact Margherita Neri and Antonio Spanevello Thorax 2000; 55 (Suppl 2): S57-S58. doi:10.1136/thorax.55.suppl_2.S57 [Extract] [Full text] [PDF] [Request Permissions]
	New evidence of inflammation in asthma Antonio M Vignola, Rosalia Gagliardo, Daniela Guerrera, Giuseppina Chiappara, Pascal Chanez, Jean Bousquet, and Giovanni Bonsignore Thorax 2000; 55 (Suppl 2): S59-S60. doi:10.1136/thorax.55.suppl_2.S59 [Extract] [Full text] [PDF] [Request Permissions]
	Allergic reactions to drugs: involvement of T cells Werner J Pichler and Nikhil Yawalkar Thorax 2000; 55 (Suppl 2): S61-S65. doi:10.1136/thorax.55.suppl_2.S61 [Extract] [Full text] [PDF] [Request Permissions]
	The aspirin disease D Schiavino, E Nucera, A Milani, M Del Ninno, A Buonomo, J Sun, and G Patriarca Thorax 2000; 55 (Suppl 2): S66-S69. doi:10.1136/thorax.55.suppl_2.S66 [Extract] [Full text] [PDF] [Request Permissions]
	Aspirin induced adverse skin reactions: new pathophysiological aspects Bettina Wedi and Alexander Kapp Thorax 2000; 55 (Suppl 2): S70-S71. doi:10.1136/thorax.55.suppl_2.S70 [Extract] [Full text] [PDF] [Request Permissions]
	Hypersensitivity to pyrazolones Micha Levy Thorax 2000; 55 (Suppl 2): S72-S74. doi:10.1136/thorax.55.suppl_2.S72 [Extract] [Full text] [PDF] [Request Permissions]
	Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies E Nucera, D Schiavino, A Milani, M Del Ninno, C Misuraca, A Buonomo, C D'Ambrosio, G Paludetti, and G Patriarca Thorax 2000; 55 (Suppl 2): S75-S78. doi:10.1136/thorax.55.suppl_2.S75 [Extract] [Full text] [PDF] [Request Permissions]
	Nasal polyposis, eosinophil dominated inflammation, and allergy Niels Mygind, Ronald Dahl, and Claus Bachert Thorax 2000; 55 (Suppl 2): S79-S83. doi:10.1136/thorax.55.suppl_2.S79 [Extract] [Full text] [PDF] [Request Permissions]
	Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different? Marek L Kowalski Thorax 2000; 55 (Suppl 2): S84-S86. doi:10.1136/thorax.55.suppl_2.S84 [Extract] [Full text] [PDF] [Request Permissions]
	Surgical treatment of nasal polyposis in patients with aspirin intolerance W Hosemann Thorax 2000; 55 (Suppl 2): S87-S90. doi:10.1136/thorax.55.suppl_2.S87 [Extract] [Full text] [PDF] [Request Permissions]